PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 15 analysts with an average price target of $35.28. This is a potential upside of $9.99 (39.5%) from yesterday's end of day stock price of $25.29.

PTC Therapeutics's activity chart (see below) currently has 122 price targets and 185 ratings on display. The stock rating distribution of PTCT is 42.42% BUY, 42.42% HOLD and 15.15% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.56% with an average time for these price targets to be met of 152.92 days.

Highest price target for PTCT is $56, Lowest price target is $17, average price target is $35.28.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 01-Mar-2024. First documented stock forecast 14-Feb-2014.

Currently out of the existing stock ratings of PTCT, 28 are a BUY (42.42%), 28 are a HOLD (42.42%), 10 are a SELL (15.15%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

28

$1.12 (4.17%)

22

1 months 18 days ago

18/22 (81.82%)

$-3.95 (-12.36%)

116

Buy

45

$18.12 (67.41%)

45

1 months 18 days ago

0/8 (0%)

$13.05 (40.85%)

Hold

30

$3.12 (11.61%)

32

1 months 18 days ago

6/7 (85.71%)

$-1.95 (-6.10%)

57

Sell

28

$1.12 (4.17%)

28

4 months ago

4/6 (66.67%)

$0.4 (1.45%)

73

Sell

18

$-8.88 (-33.04%)

22

4 months 1 days ago

3/4 (75%)

$-9.52 (-34.59%)

137

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 152.92 days on average for the stock forecasts to be realized with a an average price target met ratio 46.56

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Alethia Young has 5 price targets and 5 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kelly Shi with highest potential upside - $29.12

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Heather Behanna with lowest potential downside - -$14.88

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?